Ebermin, ointment 30 g

The drug is used in adults and children over 1 year of age for the treatment:

• surficial and deep skin burns of varying degrees;
• trophic ulcers (including. Chronic venous insufficiency, obliterating endarteritis, diabetes, rust);
• bedsores;
• durableNon-healing wounds (including residual limb wounds, wounds from autodermoplasty at lysis sites and between engrafted skin grafts, as well as residual wounds at donor sites);
• dermal integrity disorders in trauma, surgical and cosmetic interventions
• frostbites/Ulcers resulting from the administration of cytostatics;
• treatment and prevention of radiation (radiation) dermatitis (including superficial radiotherapy).

Active ingredient

Composition

The 100 g ointment contains 1 mg of human recombinant epidermal growth factor (EHRchr) and 1 g of silver sulfadiazine.

Auxiliary substances:

stearic acid – 18 g,

potassium carbonate – 500 mg,

methylparahydroxybenzoate – 180 mg,

propyl parahydroxybenzoate – 20 mg,

glycerol – 5 g,

purified water – q.s.

Special Instructions

Due to the presence of silver sulfadiazine in the drug:

Contraindications

Side effects

Ebermin is well tolerated. In rare cases: